(Q34402330)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24497460%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Ensembles of protein termini and specific proteolytic signatures as candidate biomarkers of disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24497460%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24497460%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Philipp F Lange

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24497460%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

3

Christopher M Overall

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24497460%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

27 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24497460%20AND%20SRC:MED&resulttype=core&format=json

Proteomics - Clinical Applications

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24497460%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24497460%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24497460%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

338-350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24497460%20AND%20SRC:MED&resulttype=core&format=json

Genomic medicine: bringing biomarkers to clinical medicine

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

The Path to Personalized Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

In vivo quantitative proteomics of somatosensory cortical synapses shows which protein levels are modulated by sensory deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Proteomic portrait of human breast cancer progression identifies novel prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Mass-spectrometry-based clinical proteomics--a review and prospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

The riddle of protein diagnostics: future bleak or bright?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Unleashing the power of proteomics to develop blood-based cancer markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Interpreting the protein language using proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Protein TAILS: when termini tell tales of proteolysis and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Proteases: multifunctional enzymes in life and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Missing the target: matrix metalloproteinase antitargets in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Protease signalling: the cutting edge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Amyloid precursor protein processing and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Novel research horizons for presenilins and γ-secretases in cell biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

TopFIND, a knowledgebase linking protein termini with function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Annotating N termini for the human proteome project: N termini and Nα-acetylation status differentiate stable cleaved protein species from degradation remnants in the human erythrocyte proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Tools for analyzing and predicting N-terminal protein modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

The N-end rule pathway and regulation by proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

The metalloprotease meprin β generates amino terminal-truncated amyloid β peptide species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

TopFIND 2.0--linking protein termini with proteolytic processing and modifications altering protein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Diagnostics and biomarker development: priming the pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

N- and C-terminal degradomics: new approaches to reveal biological roles for plant proteases from substrate identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Proteolytic post-translational modification of proteins: proteomic tools and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Proteome-wide analysis of protein carboxy termini: C terminomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Sampling the N-terminal proteome of human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

A targeted proteomics-based pipeline for verification of biomarkers in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Selected reaction monitoring for quantitative proteomics: a tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Method and platform standardization in MRM-based quantitative plasma proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Chapter 13. Characterizing proteolytic processing of chemokines by mass spectrometry, biochemistry, neo-epitope antibodies and functional assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Identifying and quantifying proteolytic events and the natural N terminome by terminal amine isotopic labeling of substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Differential exoprotease activities confer tumor-specific serum peptidome patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Measurement of hemoglobin A(1c): a new twist on the path to harmony

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104

Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201300104